Eam Investors, LLC Allakos Inc. Transaction History

Eam Investors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$109.73 - $153.66 $1.56 Million - $2.18 Million	-14,191 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$79.58 - $152.45 $1.13 Million - $2.16 Million	14,191 New	14,191 $1.99 Million
Q1 2020 May 13, 2020	SELL	$44.49 - $93.39 $928,817 - $1.95 Million	-20,877 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$66.49 - $137.73 $63,165 - $130,843	950 Added 4.77%	20,877 $1.99 Million
Q3 2019 Nov 13, 2019	BUY	$31.0 - $89.73 $617,737 - $1.79 Million	19,927 New	19,927 $1.57 Million

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $91.5M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.